Irritable Bowel Syndrome Therapy Tablet, Orally Disintegrating
NDC Package 17312-019-14

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Irritable Bowel Syndrome Therapy (asafetida - bismuth subnitrate - bryonia alba root - activated charcoal - lycopodium clavatum spore - sodium carbonate - strychnos nux-vomica seed - veratrum album root -) tablets is uses:**These statements are based upon traditional homeopathic practice. This formulation utilizes a tablet, orally disintegrating delivery system. Marketed by Trp Company, this product is identified by NDC 17312-019.

Identification & Billing

NDC Package Code
17312-019-14
Package Description
1 BOTTLE in 1 PACKAGE / 70 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE
Product Code
17312-019
11-Digit Billing Format
17312001914

Clinical Specifications

Proprietary Name
Irritable Bowel Syndrome Therapy
Non-Proprietary Name
Asafetida - Bismuth Subnitrate - Bryonia Alba Root - Activated Charcoal - Lycopodium Clavatum Spore - Sodium Carbonate - Strychnos Nux-vomica Seed - Veratrum Album Root -
Substance Name
Activated Charcoal; Asafetida; Bismuth Subnitrate; Bryonia Alba Root; Lycopodium Clavatum Spore; Sodium Carbonate; Strychnos Nux-vomica Seed; Veratrum Album Root
Dosage Form
Tablet, Orally Disintegrating - A solid dosage form containing medicinal substances which disintegrates rapidly, usually within a matter of seconds, when placed upon the tongue.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Pharmacologic Class
Usage Information
Uses:**These statements are based upon traditional homeopathic practice. They have not been reviewed by the Food and Drug Administration.

Regulatory & Marketing

Labeler Name
Trp Company
Product Type
Human Otc Drug
Marketing Category
UNAPPROVED HOMEOPATHIC - A category specifying that a product is marketed as unapproved homeopathic product.
Start Marketing Date
12-01-2011
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 17312-019-14 identifies a specific commercial package of 1 bottle in 1 package / 70 tablet, orally disintegrating in 1 bottle of Irritable Bowel Syndrome Therapy, a human over the counter drug labeled by Trp Company. This tablet, orally disintegrating is formulated for oral use and contains activated charcoal; asafetida; bismuth subnitrate; bryonia alba root; lycopodium clavatum spore; sodium carbonate; strychnos nux-vomica seed; veratrum album root as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Trp Company on December 01, 2011. The current certification is valid through December 31, 2026.

How is this Trp Company product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 17312001914. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
17312-019-14
11-Digit CMS (5-4-2)
17312-0019-14

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.